A PET Brain Imaging Study of mGluR5 in Subjects With Neuropsychiatric Conditions

NCT00870974 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Parkinson Disease
Huntington Disease
Autistic Spectrum Disorders
Fragile X Syndrome
Alzheimer Disease
Mild Cognitive Impairment

Interventions

DRUG: [18F]FPEB

Sponsor

Institute for Neurodegenerative Disorders